World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: SLCTR
Last refreshed on: 27 April 2013
Main ID:  SLCTR/2011/005
Date of registration: 25/03/2011
Primary sponsor: Faculty of Medicine
Public title: Effects of Melothria maderaspatana (Titta kekiri) and Passiflora foetida (Dal batu) dry fruit preparation (topical application) on renal functions of Grade II and III Chronic Kidney Disease (of unknown etiology) patients in North central Province, Sri Lanka
Scientific title: Effects of Melothria maderaspatana (Titta kekiri) and Passiflora foetida (Dal batu) dry fruit preparation (topical application) on renal functions of Grade II and III Chronic Kidney Disease (of unknown etiology) patients in North central Province, Sri Lanka
Date of first enrolment: 25/4/2011
Target sample size: 35
Recruitment status: Pending
URL:  http://www.slctr.lk/trial_details.asp?reg_id={9105D768-4383-4330-B318-EF490933BF26}
Study type:  Interventional
Study design:  Single blinded randomized controlled trial  
Countries of recruitment
Sri Lanka
Contacts
Name: Dr. M.A.C.S.Jayasumana 
Address:  Q2, FMAS, Saliyapura, Anuradhapura
Telephone: 0714393989
Email: jayasumanalk@yahoo.com
Affiliation:  Lecturer in Pharmacology, Faculty of Medicine, Rajarata University
Name: Dr. M.A.C.S.Jayasumana 
Address:  Q2, FMAS, Saliyapura, Anuradhapura
Telephone: 0714393989
Email: jayasumanalk@yahoo.com
Affiliation:  Lecturer in Pharmacology, Faculty of Medicine, Rajarata University
Key inclusion & exclusion criteria
Inclusion criteria: a)Diagnosed patients of having grade II and III CKDu, Normal HbA1C (and#706;6.5%) and BPand#706;160/100 mmHg untreated or and#706;140/90 mmHg on up to two antihypertensive agents, Persistent albuminuria + eGFR 30- 89 mi/min/1.73m2


b)Age between 20-60 years


c)Permanent residents of Anuradhapura or Polonnaruwa district, for at least 5 years prior to diagnosis as Grade II or III CKDu

Exclusion criteria: a)Patients with no past history of or current treatment for diabetes mellitus or chronic and/or severe hypertension, snakebite, urological disease of known etiology or glomerulonephritis

b)Patients who are suffering with other chronic diseases or on treatment for any other disease other than CKDu

c)Patients aged less than 20 years and more than 65 years

d)Pregnant and breast feeding mothers

e)Patients who live outside the NCP,are not permanent resident within NCP at least 5 years prior to diagnose as CKDu and residents in GN divisions where WHO is conducting the Study for CKDu


Age minimum:
Age maximum:
Gender:
Health Condition(s) or Problem(s) studied
Chronic Kidney Disease (of unknown etiology
Intervention(s)
Paste of dried Melothria maderaspatana (Titta kekiri) and Passiflora foetida (Dal batu) will be applied for 6 hours daily to the big toe of test group for a period of 10 months.
Placebo paste will be applied to the controls in a smiliar manner for the same period
Primary Outcome(s)
1.Full blood count

2.Lipid profile

3.Renal profile

4.Liver enzymes-SGPT and SGOT

5.Urine full report including and#946;2 globulin level

6.IFNand#948;

7.TNFand#945;

8.HSP70
Secondary Outcome(s)
Secondary ID(s)
Nil known
Source(s) of Monetary Support
University Grants Commission - Sri Lanka
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history